Volume 13 Issue 4
Jul.  2022
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2022  >  13(4): 417-424
Jiao Guohui, Wang Zitao, Chen Jingyu. Current status and prospect of global development of lung transplantation[J]. ORGAN TRANSPLANTATION, 2022, 13(4): 417-424. doi: 10.3969/j.issn.1674-7445.2022.04.002
Citation: Jiao Guohui, Wang Zitao, Chen Jingyu. Current status and prospect of global development of lung transplantation[J]. ORGAN TRANSPLANTATION, 2022, 13(4): 417-424. doi: 10.3969/j.issn.1674-7445.2022.04.002
shu

Current status and prospect of global development of lung transplantation

doi: 10.3969/j.issn.1674-7445.2022.04.002

  • The Affiliated Wuxi People's Hospital of Nanjing Medical University, Jiangsu Lung Transplant Center, Wuxi Lung Transplant Center, Wuxi 214000, China

More Information
  • Corresponding author: Chen Jingyu, Email: chenjy@wuxiph.com
  • Received Date: 2022-04-14
    Available Online: 2022-07-14
  • Publish Date: 2022-07-15
    Abstract
  • During the novel coronavirus pneumonia (COVID-19) pandemic from 2020 to 2021, lung transplantation entered a new stage of development worldwide. Globally, more than 70 000 cases of lung transplantation have been reported to the International Society for Heart and Lung Transplantation (ISHLT). With the development of medical techniques over time, the characteristics of lung transplant donors and recipients and the indications of pediatric lung transplantation recipients have undergone significant changes. Application of lung transplantation in the treatment of COVID-19-related acute respiratory distress syndrome (ARDS) has also captivated worldwide attention. Along with persistent development of lung transplantation, it will be integrated with more novel techniques to make breakthroughs in the fields of artificial lung and xenotransplantation. In this article, research progresses on the characteristics of lung transplant donors and recipients around the world were reviewed and the development trend was predicted, enabling patients with end-stage lung disease to obtain more benefits from the development of lung transplantation technique.

     

    • FullText(HTML)
  • loading
    • References(52)
  • [1]
    RUCKER AJ, NELLIS JR, KLAPPER JA, et al. Lung retransplantation in the modern era[J]. J Thorac Dis, 2021, 13(11): 6587-6593. DOI: 10.21037/jtd-2021-25.
    [2]
    YUSEN RD, CHRISTIE JD, EDWARDS LB, et al. The Registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heart-lung transplant report--2013; focus theme: age[J]. J Heart Lung Transplant, 2013, 32(10): 965-978. DOI: 10.1016/j.healun.2013.08.007.
    [3]
    YUSEN RD, EDWARDS LB, DIPCHAND AI, et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-third adult lung and heart-lung transplant report-2016; focus theme: primary diagnostic indications for transplant[J]. J Heart Lung Transplant, 2016, 35(10): 1170-1184. DOI: 10.1016/j.healun.2016.09.001.
    [4]
    YUSEN RD, EDWARDS LB, KUCHERYAVAYA AY, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report--2014; focus theme: retransplantation[J]. J Heart Lung Transplant, 2014, 33(10): 1009-1024. DOI: 10.1016/j.healun.2014.08.004.
    [5]
    YUSEN RD, EDWARDS LB, KUCHERYAVAYA AY, et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-second official adult lung and heart-lung transplantation report--2015; focus theme: early graft failure[J]. J Heart Lung Transplant, 2015, 34(10): 1264-1277. DOI: 10.1016/j.healun.2015.08.014.
    [6]
    CHAMBERS DC, YUSEN RD, CHERIKH WS, et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult lung and heart-lung transplantation report-2017; focus theme: allograft ischemic time[J]. J Heart Lung Transplant, 2017, 36(10): 1047-1059. DOI: 10.1016/j.healun.2017.07.016.
    [7]
    CHAMBERS DC, CHERIKH WS, GOLDFARB SB, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-fifth adult lung and heart-lung transplant report-2018; focus theme: multiorgan transplantation[J]. J Heart Lung Transplant, 2018, 37(10): 1169-1183. DOI: 10.1016/j.healun.2018.07.020.
    [8]
    CHAMBERS DC, CHERIKH WS, HARHAY MO, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult lung and heart-lung transplantation report-2019; focus theme: donor and recipient size match[J]. J Heart Lung Transplant, 2019, 38(10): 1042-1055. DOI: 10.1016/j.healun.2019.08.001.
    [9]
    CHAMBERS DC, PERCH M, ZUCKERMANN A, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-eighth adult lung transplantation report - 2021; focus on recipient characteristics[J]. J Heart Lung Transplant, 2021, 40(10): 1060-1072. DOI: 10.1016/j.healun.2021.07.021.
    [10]
    CHAMBERS DC, ZUCKERMANN A, CHERIKH WS, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult lung transplantation report - 2020; focus on deceased donor characteristics[J]. J Heart Lung Transplant, 2020, 39(10): 1016-1027. DOI: 10.1016/j.healun.2020.07.009.
    [11]
    KUKREJA J, CHEN J, BRZEZINSKI M. Redefining marginality: donor lung criteria[J]. Curr Opin Organ Transplant, 2020, 25(3): 280-284. DOI: 10.1097/MOT.0000000000000764.
    [12]
    KHAN B, SINGER LG, LILLY LB, et al. Successful lung transplantation from hepatitis C positive donor to seronegative recipient[J]. Am J Transplant, 2017, 17(4): 1129-1131. DOI: 10.1111/ajt.14137.
    [13]
    CYPEL M, YEUNG JC, LIU M, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation[J]. N Engl J Med, 2011, 364(15): 1431-1440. DOI: 10.1056/NEJMoa1014597.
    [14]
    WARNECKE G, VAN RAEMDONCK D, SMITH MA, et al. Normothermic ex-vivo preservation with the portable organ care system lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study[J]. Lancet Respir Med, 2018, 6(5): 357-367. DOI: 10.1016/S2213-2600(18)30136-X.
    [15]
    HOZAIN AE, O'NEILL JD, PINEZICH MR, et al. Xenogeneic cross-circulation for extracorporeal recovery of injured human lungs[J]. Nat Med, 2020, 26(7): 1102-1113. DOI: 10.1038/s41591-020-0971-8.
    [16]
    VALAPOUR M, LEHR CJ, SKEANS MA, et al. OPTN/SRTR 2020 annual data report: lung[J]. Am J Transplant, 2022, 22(Suppl 2): 438-518. DOI: 10.1111/ajt.16991.
    [17]
    LEARD LE, HOLM AM, VALAPOUR M, et al. Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation[J]. J Heart Lung Transplant, 2021, 40(11): 1349-1379. DOI: 10.1016/j.healun.2021.07.005.
    [18]
    ZORN GL JR, MCGIFFIN DC, YOUNG KR JR, et al. Pulmonary transplantation for advanced bronchioloalveolar carcinoma[J]. J Thorac Cardiovasc Surg, 2003, 125(1): 45-48. DOI: 10.1067/mtc.2003.72.
    [19]
    AVDIMIRETZ N, BENDEN C. The changing landscape of pediatric lung transplantation[J]. Clin Transplant, 2022, 36(4): e14634. DOI: 10.1111/ctr.14634.
    [20]
    KIMURA N, KHAN MS, SCHECTER M, et al. Changing demographics and outcomes of lung transplantation recipients with cystic fibrosis[J]. J Heart Lung Transplant, 2016, 35(10): 1237-1244. DOI: 10.1016/j.healun.2016.06.002.
    [21]
    BESSONOVA L, VOLKOVA N, HIGGINS M, et al. Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor[J]. Thorax, 2018, 73(8): 731-740. DOI: 10.1136/thoraxjnl-2017-210394.
    [22]
    ROSENZWEIG EB, ABMAN SH, ADATIA I, et al. Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management[J]. Eur Respir J, 2019, 53(1): 1801916. DOI: 10.1183/13993003.01916-2018.
    [23]
    YUE B, WU B, ZHANG J, et al. Pediatric lung transplantation in the largest lung transplantation center of China: embarking on a long road[J]. Sci Rep, 2020, 10(1): 12471. DOI: 10.1038/s41598-020-69340-0.
    [24]
    SWEET SC. Pediatric lung transplantation[J]. Respir Care, 2017, 62(6): 776-798. DOI: 10.4187/respcare.05304.
    [25]
    HUANG J, PAN J, WANG Z, et al. BLTx combined with cardiac correction in treatment of PAH in puerpera: is it a feasible strategy?[J]. Ann Thorac Surg, 2021, 111(4): e249-e251. DOI: 10.1016/j.athoracsur.2020.06.125.
    [26]
    KURLAND G, DETERDING RR, HAGOOD JS, et al. An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy[J]. Am J Respir Crit Care Med, 2013, 188(3): 376-394. DOI: 10.1164/rccm.201305-0923ST.
    [27]
    BUSH A, CUNNINGHAM S, DE BLIC J, et al. European protocols for the diagnosis and initial treatment of interstitial lung disease in children[J]. Thorax, 2015, 70(11): 1078-1084. DOI: 10.1136/thoraxjnl-2015-207349.
    [28]
    CHUA F, DESAI SR, NICHOLSON AG, et al. Pleuroparenchymal fibroelastosis. a review of clinical, radiological, and pathological characteristics[J]. Ann Am Thorac Soc, 2019, 16(11): 1351-1359. DOI: 10.1513/AnnalsATS.201902-181CME.
    [29]
    ELDRIDGE WB, ZHANG Q, FARO A, et al. Outcomes of lung transplantation for infants and children with genetic disorders of surfactant metabolism[J]. J Pediatr, 2017, 184: 157-164. DOI: 10.1016/j.jpeds.2017.01.017.
    [30]
    LIU F, JIN YL, LI HX, et al. Pediatric case report: successful bilateral lung transplantation performed to treat an 8-year-old girl with pulmonary interstitial fibrosis due to surfactant protein (SP)-C gene mutation[J]. Chin Med J (Engl), 2020, 134(4): 498-500. DOI: 10.1097/CM9.0000000000001053.
    [31]
    ZHANG H, DAI H, XIE X. Solid organ transplantation during the COVID-19 pandemic[J]. Front Immunol, 2020, 11: 1392. DOI: 10.3389/fimmu.2020.01392.
    [32]
    CHEN JY, QIAO K, LIU F, et al. Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis[J]. Chin Med J (Engl), 2020, 133(12): 1390-1396. DOI: 10.1097/CM9.0000000000000839.
    [33]
    WU B, HUANG M, JIAO G, et al. Lung transplantation during the outbreak of coronavirus disease 2019 in China[J]. J Thorac Cardiovasc Surg, 2022, 163(1): 326-335. DOI: 10.1016/j.jtcvs.2020.10.154.
    [34]
    WANG B, HUANG J, HSIN M, et al. First lung transplant in Wuhan for a critical and elderly COVID-19 patient[J]. Immun Inflamm Dis, 2021, 9(4): 1500-1507. DOI: 10.1002/iid3.501.
    [35]
    ROACH A, CHIKWE J, CATARINO P, et al. Lung transplantation for COVID-19-related respiratory failure in the United States[J]. N Engl J Med, 2022, 386(12): 1187-1188. DOI: 10.1056/NEJMc2117024.
    [36]
    BHARAT A, MACHUCA TN, QUERREY M, et al. Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries[J]. Lancet Respir Med, 2021, 9(5): 487-497. DOI: 10.1016/S2213-2600(21)00077-1.
    [37]
    KO RE, OH DK, CHOI SM, et al. Lung transplantation for severe COVID-19-related ARDS[J]. Ther Adv Respir Dis, 2022, 16: 17534666221081035. DOI: 10.1177/17534666221081035.
    [38]
    KURIHARA C, MANERIKAR A, QUERREY M, et al. Clinical characteristics and outcomes of patients with COVID-19-associated acute respiratory distress syndrome who underwent lung transplant[J]. JAMA, 2022, 327(7): 652-661. DOI: 10.1001/jama.2022.0204.
    [39]
    WOOLLEY AE, MEHRA MR. Dilemma of organ donation in transplantation and the COVID-19 pandemic[J]. J Heart Lung Transplant, 2020, 39(5): 410-411. DOI: 10.1016/j.healun.2020.03.017.
    [40]
    HUANG J, TIAN D, CHEN J. A modified lobar transplants combining RUL and RML for small recipients[J]. Ann Thorac Surg, 2022, 113(6): 2103-2104. DOI: 10.1016/j.athoracsur.2021.03.080.
    [41]
    RECK DOS SANTOS PA, CYPEL M. An ingenious approach for lobar lung transplantation[J]. Ann Thorac Surg, 2022, 113(6): 2104. DOI: 10.1016/j.athoracsur.2021.05.006.
    [42]
    THIAGARAJAN RR, BARBARO RP, RYCUS PT, et al. Extracorporeal life support organization registry international report 2016[J]. ASAIO J, 2017, 63(1): 60-67. DOI: 10.1097/MAT.0000000000000475.
    [43]
    RUSZEL N, KIEŁBOWSKI K, PIOTROWSKA M, et al. Central, peripheral ECMO or CPB? comparsion between circulatory support methods used during lung transplantation[J]. J Cardiothorac Surg, 2021, 16(1): 341. DOI: 10.1186/s13019-021-01719-0.
    [44]
    HOETZENECKER K, SCHWARZ S, MUCKENHUBER M, et al. Intraoperative extracorporeal membrane oxygenation and the possibility of postoperative prolongation improve survival in bilateral lung transplantation[J]. J Thorac Cardiovasc Surg, 2018, 155(5): 2193-2206. DOI: 10.1016/j.jtcvs.2017.10.144.
    [45]
    SHAH A, AWAD MA, WU ZJ, et al. Ambulatory home wearable lung: progress and future directions[J]. Rev Cardiovasc Med, 2021, 22(4): 1405-1411. DOI: 10.31083/j.rcm2204145.
    [46]
    WELKER C, HUANG J, RAMAKRISHNA H. Analysis of the 2020 EACTS/ELSO/STS/AATS expert guidelines on the management of adult postcardiotomy extracorporeal life support[J]. J Cardiothorac Vasc Anesth, 2022, 36(7): 2207-2219. DOI: 10.1053/j.jvca.2021.06.022.
    [47]
    POSLUSZNY J, ENGOREN M, NAPOLITANO LM, et al. Predicting survival of adult respiratory failure patients receiving prolonged (≥14 days) extracorporeal membrane oxygenation[J]. ASAIO J, 2020, 66(7): 825-833. DOI: 10.1097/MAT.0000000000001067.
    [48]
    KARAGIANNIDIS C, JOOST T, STRASSMANN S, et al. Safety and efficacy of a novel pneumatically driven extracorporeal membrane oxygenation device[J]. Ann Thorac Surg, 2020, 109(6): 1684-1691. DOI: 10.1016/j.athoracsur.2020.01.039.
    [49]
    WIEGMANN B, VON SEGGERN H, HÖFFLER K, et al. Developing a biohybrid lung - sufficient endothelialization of poly-4-methly-1-pentene gas exchange hollow-fiber membranes[J]. J Mech Behav Biomed Mater, 2016, 60: 301-311. DOI: 10.1016/j.jmbbm.2016.01.032.
    [50]
    DABAGHI M, ROCHOW N, SARAEI N, et al. A pumpless microfluidic neonatal lung assist device for support of preterm neonates in respiratory distress[J]. Adv Sci (Weinh), 2020, 7(21): 2001860. DOI: 10.1002/advs.202001860.
    [51]
    KIRK AD. When pigs fly[J]. Am J Transplant, 2022, 22(4): 1007-1008. DOI: 10.1111/ajt.16963.
    [52]
    BURDORF L, LAIRD CT, HARRIS DG, et al. Pig-to-baboon lung xenotransplantation: extended survival with targeted genetic modifications and pharmacologic treatments[J]. Am J Transplant, 2022, 22(1): 28-45. DOI: 10.1111/ajt.16809.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (988) PDF downloads(226) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return